Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza a (H5N1) virus expressed in insect cells and bacteria

被引:35
作者
Shen, Shuo [1 ]
Mahadevappa, Geetha [1 ]
Oh, Hsueh-Ling Janice [1 ]
Wee, Boon Yu [1 ]
Choi, Yook-Wah [1 ]
Hwang, Le-Ann [2 ]
Lim, Seng Gee [1 ]
Hong, Wanjin [3 ]
Lal, Sunil K. [1 ,4 ]
Tan, Yee-Joo [1 ]
机构
[1] Inst Mol & Cell Biol, Collaborat Anti Viral Res Grp, Singapore 138673, Singapore
[2] Inst Mol & Cell Biol, Monoclonal Antibody Unit, Singapore 138673, Singapore
[3] Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 138673, Singapore
[4] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India
关键词
baculovirus; neutralizing antibodies; membrane fusion; HA5 pseudotyped lentiviral particles;
D O I
10.1002/jmv.21298
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The hemagglutinin (HA) of influenza A virus plays an essential role in mediating the entry of the virus into host cells. Here, recombinant full-length HA5 protein from a H5N1 isolate (A/chicken/hatay/2004(H5N1)) was expressed and purified from the baculovirus-insect cell system. As expected, full-length HA5 elicits strong neutralizing antibodies, as evaluated in micro-neutralization tests using HA5 pseudotyped lentiviral particles. In addition, two fragments of HA5 were expressed in bacteria and the N-terminal fragment, covering the ectodomain before the HA1/HA2 polybasic cleavage site, was found to elicit neutralizing antibodies. But the C-terminal fragment, which covers the remaining portion of the ectodomain, did not. Neutralizing titer of the anti-serum against the N-terminal fragment is only four times lower than the antiserum against the full-length HA5 protein. Using a novel membrane fusion assay, the abilities of these antibodies to block membrane fusion were found to correlate well with the neutralization activities.
引用
收藏
页码:1972 / 1983
页数:12
相关论文
共 24 条
[1]   Current concepts - Avian influenza A (H5N1) infection in humans [J].
Beigel, H ;
Farrar, H ;
Han, AM ;
Hayden, FG ;
Hyer, R ;
de Jong, MD ;
Lochindarat, S ;
Tien, NTK ;
Hien, NT ;
Hien, TT ;
Nicoll, A ;
Touch, S ;
Yuen, KY .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1374-1385
[2]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[3]   The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection [J].
Coulibaly, S ;
Brühl, P ;
Mayrhofer, J ;
Schmid, K ;
Gerencer, M ;
Falkner, FG .
VIROLOGY, 2005, 341 (01) :91-101
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRAL-PROTEIN-R (VPR) ARRESTS CELLS IN THE G(2) PHASE OF THE CELL-CYCLE BY INHIBITING P34(CDC2) ACTIVITY [J].
HE, JL ;
CHOE, S ;
WALKER, R ;
DIMARZIO, P ;
MORGAN, DO ;
LANDAU, NR .
JOURNAL OF VIROLOGY, 1995, 69 (11) :6705-6711
[5]   Strategies for developing vaccines against H5N1 influenza A viruses [J].
Horimoto, Taisuke ;
Kawaoka, Yoshihiro .
TRENDS IN MOLECULAR MEDICINE, 2006, 12 (11) :506-514
[6]   Changing perspective on immunization against influenza [J].
Johansson, Bert E. ;
Brett, Ian C. .
VACCINE, 2007, 25 (16) :3062-3065
[7]   Pathogenesis of and immunity to avian influenza A H5 viruses [J].
Katz, JM ;
Lu, X ;
Frace, AM ;
Morken, T ;
Zaki, SR ;
Tumpey, TM .
BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (04) :178-187
[8]   Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents [J].
Keng, CT ;
Zhang, A ;
Shen, S ;
Lip, KM ;
Fielding, BC ;
Tan, THP ;
Chou, CF ;
Loh, CB ;
Wang, SF ;
Fu, JL ;
Yang, XM ;
Lim, SG ;
Hong, WJ ;
Tan, YJ .
JOURNAL OF VIROLOGY, 2005, 79 (06) :3289-3296
[9]  
KILBOURNE ED, 1987, INFLUENZA, P164
[10]   Baculovirus as versatile vectors for protein expression in insect and mammalian cells [J].
Kost, TA ;
Condreay, JP ;
Jarvis, DL .
NATURE BIOTECHNOLOGY, 2005, 23 (05) :567-575